PERIANAL COMPLETE REMISSION WITH COMBINED THERAPY (SETON PLACEMENT AND ANTI-TNF AGENTS) IN Crohn’s DISEASE: a Brazilian multicenter observational study

KOTZE, Paulo Gustavo; ALBUQUERQUE, Idblan Carvalho de; MOREIRA, André da Luz; TONINI, Wanessa Bertrami; OLANDOSKI, Marcia; COY, Claudio Saddy Rodrigues.
Arq. gastroenterol ; 51(4): 284-289, Oct-Dec/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-732201

Documentos relacionados

  1. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study.
  2. Clinical characteristics and treatment of perianal fistulising Crohn's disease in Colombia: Results of a multicentric registry.
  3. Allogenic stem cells for Crohn's anal fistulas: Treating early improves the deep remission rate.
  4. Tumor Necrosis Factor's Pathway in Crohn's Disease: Potential for Intervention.
  5. Durable Response in Patients With Refractory Fistulizing Perianal Crohn's Disease Using Autologous Mesenchymal Stem Cells on a Dissolvable Matrix: Results from the Phase I Stem Cell on Matrix Plug Trial.
  6. [Clinical characteristics and prognosis of children with perianal fistulizing Crohn's disease].
  7. A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease.
  8. Managing perianal Crohn's fistula in the anti-TNFα era.
  9. Management of perianal fistulas in Crohn's disease: a 2021 update of the French National Society of Coloproctology consensus.
  10. Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU.